EDQM: Policy for CEP Applications published for Comments
Recommendation
Thursday, 13 February 2025 10.30 - 15.45 h
Focus on CADIFA and obtaining a Brazilian GMP certificate
In June, the draft Certification Policy Document PA/PH/CEP(04) 1, 6R "Content of the dossier for CEP applications for chemical purity and microbiological quality of substances for pharmaceutical use" was published on the EDQM (European Directorate for the Quality of Medicines & HealthCare) website for comments. Comments and remarks on this draft can be submitted until 15 September 2023. Following the consultation period, the final document will be published on the EDQM website.
This draft is intended to provide guidance for applicants for a CEP (Certificate of Suitability). It applies to all substances listed in the European Pharmacopoeia for which the certification procedure is relevant. These are mainly active substances, but excipients described in the monographs may also be included. However, the requirements for excipients may differ from the requirements for active substances.
The draft for comment explains that a new CEP application should contain three modules.
The facts to be included in modules 1-3 are listed and explained in detail in the policy document. In principle, the structure should be as follows:
- Module 1: Cover Letter and Complete Application
- Module 2: Quality Overall Summary
- Module 3: Structure according to the CTD, i.e. analogous to ICH M4.
Related GMP News
10.12.2024EDQM: New guideline for sterile substances published
10.12.2024eSubmission: Updates of 'Validation Criteria'
06.11.2024Inadequate Classification leads to Warning Letter
17.10.2024ICH E11A: Final version published
16.10.2024EMA: Update of the Q&A Documents for "Centralised Procedures"